Archive for November 2011

[vc_row][vc_column][vc_column_text] Significant Reduction in Re-Excision Rate Documented by German Researchers Framingham, MA, November 30, 2011- A clinical study to be published in the upcoming issue of the journal “The Breast”, describes the use of Dilon’s MarginProbe System as an adjunct to the standard of care in lumpectomy surgeries of women with early stage ductal carcinoma…

[vc_row][vc_column][vc_column_text] New Code Represents a Major Step in Securing Widespread Reimbursement Framingham, MA, November 28, 2011- The German Ministry of Health has published a new and unique procedure code for Dilon’s MarginProbe System, which becomes effective on January 1, 2012. Use of this procedure code is the first step in securing reimbursement for new medical…

[vc_row][vc_column][vc_column_text]Framingham, MA, November 23, 2011-Dilon Devices, Inc. today announced that its CEO, Dan Levangie, will participate in the 23rd Annual Piper Jaffray Healthcare Conference and will present an overview of Dilon Devices at 3:10 PM on Wednesday, November 30, 2011. The Piper Jaffray Healthcare Conference, being held on November 29 & 30, 2011 at the…

[vc_row][vc_column][vc_column_text] Management Adds Experienced Financial Executive Framingham, MA, November 23, 2011. Dilon Devices announced today the appointment of Roger Blanchette as Senior Vice President and Chief Financial Officer, effective immediately. Mr. Blanchette was formerly Executive Vice President and Chief Financial Officer of Cadent, Inc. through Cadent’s acquisition by Align Technologies, Inc. in April 2011. In…